AYURVEDIC TREATMENT OF PROSTATE (MOOTRAGHAT)

Phase 2

Completed

• Conditions: Disorder of urinary system, unspecified, Patients having signs and symptoms of mootraghat (BPH) as per Modern and Ayurveda considering Doshic variance of mootraghat. ,

• Registration Number: CTRI/2018/04/013226
• Lead Sponsor: Institute for post graduation teaching and research in ayurveda

Brief Summary

**Methodology:**In clinical study, patients of *Mutraghata* (BPH) were selected and dividedrandomly by computerized randomization method into two groups. They were treatedwith the formulations of *Kanchnar Guggulu*and  *Bala* *Taila matra basti* ingroup-A and *Varun-Shigru Guggulu* and *BalaTail* *Matra* *basti* in group-B. The treatment was instituted forthe duration of 21 days. Out of 81 patients, 40 patients in group A and 41patients in group B were completed therapy as well as follow up period. All thepatients were assessed as per subjective and objective criteria adopted duringthe study & the findings were recorded in the clinical research performa.

**Results:**Statisticallyhighly significant (p<0.0001) result was noted in almost all the symptomsi.e. increased frequency, nocturia, weak stream, incomplete voiding in thepatients of both groups.

In Group-A statically highly significant (p<0.0001)result was observed in average urine flow rate and prostate size, and in postvoidal residual urine. In Group-B statistically highly significant(p<0.0001) result was noted on size of enlarged prostate gland and inaverage urine flow rate, while (p<0.05) significant changes were observed inpost voidal residual urine volume.

In case of laboratory investigationsspecifically Sr. PSA (Ptostate specific antigen) in almost maximum patientsthese values remained similar before & after the treatment so statisticallynon significant (p>0.05) results found

**Conclusion:**Finally study concluded that *KanchnarGuggulu* and *Va**runa Shigru Guggulu*orally along with *Bala* *Taila Matra Basti* is safe and foundequally effective in management of *Mutraghata*(BPH).

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-05
• Study Completion: 2020-01-29
• Last Update Posted: 2023-06-13

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

• Increased Frequency /Urgency 2.
• Hesitancy 3.
• Decreased Urine Flow Rate / Weak Stream) 4.
• Acute/Chronic Urine Retention!
• Scanty Micturation 6.
• Painful Micturation 7.
• Dysuria- Burning Micturation 8.
• Controlled cases of Diabetes and controlled Hypertension patients will be included in the study.

Exclusion Criteria

• Patients of age below 40 years.
• Patients of malignancy, congenital deformities of urogenital tract or any abdomino-pelvic pathology.
• Systemic diseases like Uncontrolled Hypertension and uncontrolled Diabetes, uncontrolled TB, Paralysis, Parkinsonism etc.
• will be excluded.
• Known cases of HIV, VDRL, HbsAg will be excluded.
• Patients with heart disease like IHD, MI, Angina, etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sign and Symptoms of BPH will reduce with treatment.	21 days

Secondary Outcome Measures

Name	Time	Method
improvement in quality of life	2 months

Trial Locations

Locations (1)

SHALYA TANTRA DEPARTMENT IPGT RA; 🇮🇳 Jamnagar, GUJARAT, India

SHALYA TANTRA DEPARTMENT IPGT RA

🇮🇳Jamnagar, GUJARAT, India

PRIYANKA CHAUHAN

Principal investigator

8460320847

drpriyankachauhan24@gmail.com